Withdrawal-related changes in delay discounting predict short-term smoking abstinence

Nicotine and Tobacco Research

Volumn 19, Issue 6, 2017, Pages 694-702

  Miglin, Rickie ^a   Kable, Joseph W ^b   Bowers, Maureen E ^c   Ashare, Rebecca L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CRAVING; DECISION MAKING; DELAY DISCOUNTING; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; RELAPSE; REWARD; SMOKING CESSATION; SMOKING HABIT; TIME PERCEPTION; MOTIVATION; PROCEDURES; PSYCHOLOGY; SMOKING; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ADULT; DELAY DISCOUNTING; FEMALE; HUMANS; MALE; MOTIVATION; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 85020173491     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw246     Document Type: Article

References (87)

1. Schroeder SA. New evidence that cigarette smoking remains the most important health hazard. N Engl J Med. 2013;368(4):389-390. doi:10.1056/NEJMe1213751.
2. Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav. 1992;17(4):367-377. doi:10.1016/0306-4603(92)90042-T.
3. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29-38. doi:10.1111/j.1360-0443.2004.00540.x.
4. Ashare RL, Wileyto EP, Perkins KA, Schnoll RA. The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence. J Addict Med. 2013;7(4):249-254. doi:10.1097/ADM.0b013e31829363e1.
5. Perkins KA, Lerman C, Fonte CA, et al. Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther. 2010;88(1):109-114. doi:10.1038/clpt.2010.65.
6. Patterson F, Jepson C, Strasser AA, et al. Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry. 2009;65(2):144-149. doi:10.1016/j.biopsych.2008.08.028.
7. Perkins KA, Lerman C, Stitzer M, et al. Development of procedures for early screening of smoking cessation medications in humans. Clin Pharmacol Ther. 2008;84(2):216-221. 10.1038/clpt.2008.30.
8. Rachlin H, Green L. Commitment, choice and self-control. J Exp Anal Behav. 1972;17(1):15-22. www.ncbi.nlm.nih.gov/pubmed/16811561. Accessed August 29, 2014.
9. Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull. 1975;82(4):463-496. www.ncbi.nlm.nih.gov/pubmed/1099599. Accessed August 29, 2014.
10. de Wit H, Richards JB. Dual determinants of drug use in humans: reward and impulsivity. Nebr Symp Motiv. 2004;50:19-55. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&.
11. de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009;14(1):22-31. doi:10.1111/j.1369-1600.2008.00129.x.
12. Audrain-McGovern J, Rodriguez D, Epstein LH, Cuevas J, Rodgers K, Wileyto EP. Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend. 2009;103(3):99-106. doi:10.1016/j.drugalcdep.2008.12.019.
13. Bickel WK, Odum AL, Madden GJ. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl). 1999;146(4):447-454. www.ncbi.nlm.nih.gov/pubmed/10550495.
14. Epstein LH, Richards JB, Saad FG, Paluch RA, Roemmich JN, Lerman C. Comparison between two measures of delay discounting in smokers. Exp Clin Psychopharmacol. 2003;11(2):131-138. www.ncbi.nlm.nih.gov/pubmed/12755457. Accessed August 29, 2014.
15. Ohmura Y, Takahashi T, Kitamura N. Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes. Psychopharmacology (Berl). 2005;182(4):508-515. doi10.1007/s00213-005-0110-8.
16. Reynolds B. Do high rates of cigarette consumption increase delay discounting? A cross-sectional comparison of adolescent smokers and young-adult smokers and nonsmokers. Behav Processes. 2004;67(3):545-549. doi:10.1016/j.beproc.2004.08.006.
17. Sweitzer MM, Donny EC, Dierker LC, Flory JD, Manuck SB. Delay discounting and smoking: association with the Fagerstrom Test for Nicotine Dependence but not cigarettes smoked per day. Nicotine Tob Res. 2008;10(10):1571-1575. doi:10.1080/14622200802323274.
18. Litvin EB, Brandon TH. Testing the influence of external and internal cues on smoking motivation using a community sample. Exp Clin Psychopharmacol. 2010;18(1):61-70. doi:10.1037/a0017414.
19. Yi R, Landes RD. Temporal and probability discounting by cigarette smokers following acute smoking abstinence. Nicotine Tob Res. 2012;14(5):547-558. doi:10.1093/ntr/ntr252.
20. Field M, Santarcangelo M, Sumnall H, Goudie A, Cole J. Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacology (Berl). 2006;186(2):255-263. doi:10.1007/s00213-006-0385-4.
21. Ashare RL, Kable JW. Sex differences in time perception during smoking abstinence. Nicotine Tob Res. 2015;17(4):449-454. doi:10.1093/ntr/ntu260.
22. Ashare RL, Hawk LW Jr. Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms. Psychopharmacology (Berl). 2012;219(2):537-547. doi:10.1007/s00213-011-2324-2.
23. Yoon JH, Higgins ST, Heil SH, Sugarbaker RJ, Thomas CS, Badger GJ. Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol. 2007;15(2):176-186. doi:10.1037/1064-1297.15.2.186.
24. Krishnan-Sarin S, Reynolds B, Duhig AM, et al. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend. 2007;88(1):79-82. doi:10.1016/j. drugalcdep.2006.09.006.
25. Sheffer C, Mackillop J, McGeary J, et al. Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers. Am J Addict. 2012;21(3):221-232. doi:10.1111/j.1521-0391.2012.00224.x.
26. MacKillop J, Kahler CW. Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend. 2009;104(3):197-203. doi:10.1016/j. drugalcdep.2009.04.020.
27. Sheffer CE, Christensen DR, Landes R, Carter LP, Jackson L, Bickel WK. Delay discounting rates: a strong prognostic indicator of smoking relapse. Addict Behav. 2014;39(11):1682-1689. doi10.1016/j. addbeh.2014.04.019.
28. Kable JW, Glimcher PW. The neural correlates of subjective value during intertemporal choice. Nat Neurosci. 2007;10(12):1625-1633. doi:10.1038/nn2007.
29. Kable JW, Glimcher PW. The neurobiology of decision: consensus and controversy. Neuron. 2009;63(6):733-745. doi:10.1016/j. neuron.2009.09.003.
30. Kable JW, Glimcher PW. An "as soon as possible" effect in human inter-temporal decision making: behavioral evidence and neural mechanisms. J Neurophysiol. 2010;103(5):2513-2531. doi:10.1152/jn.00177.2009.
31. Takahashi T. Time-estimation error following Weber-Fechner law may explain subadditive time-discounting. Medical Hypotheses. 2006;67(6):1372-1374. doi:10.1016/j.mehy.2006.05.056.
32. Rubia K, Halari R, Christakou A, Taylor E. Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. Philos Trans R Soc Lond B Biol Sci. 2009;364(1525):1919-1931. doi:10.1098/rstb.2009.0014.
33. Keough KA, Zimbardo PG, Boyd JN. Who's smoking, drinking, and using drugs? Time perspective as a predictor of substance use. Basic Appl Social Psychol. 1999;21(2):149-164. doi:10.1207/s15324834ba210207.
34. Rammsayer TH. Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans? Neuropsychobiology. 2008;35(1):36-45. doi:10.1159/000119328.
35. Petry NM, Bickel WK, Arnett M. Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction. 1998;93(5):729-738. www.ncbi.nlm.nih.gov/pubmed/9692271.
36. Williamson LL, Cheng RK, Etchegaray M, Meck WH. "Speed" warps time: methamphetamine's interactive roles in drug abuse, habit formation, and the biological clocks of circadian and interval timing. Curr Drug Abuse Rev. 2008;1(2):203-212.
37. Wittmann M, Leland DS, Churan J, Paulus MP. Impaired time perception and motor timing in stimulant-dependent subjects. Drug Alcohol Depend. 2007;90(2-3):183-192. doi:10.1016/j.drugalcdep.2007.03.005.
38. Takahashi T. Loss of self-control in intertemporal choice may be attributable to logarithmic time-perception. Medical Hypotheses. 2005;65(4):691-693. doi:10.1016/j.mehy.2005.04.040.
39. Sayette MA, Loewenstein G, Kirchner TR, Travis T. Effects of smoking urge on temporal cognition. Psychol Addict Behav. 2005;19(1):88-93. doi:10.1037/0893-164X.19.1.88.
40. Klein LC, Corwin EJ, Stine MM. Smoking abstinence impairs time estimation accuracy in cigarette smokers. Psychopharmacol Bull. 2003;37(1):90-95. www.ncbi.nlm.nih.gov/pubmed/14561951. Accessed August 29, 2014.
41. Loughead J, Wileyto EP, Ruparel K, et al. Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology. 2015;40(6):1311-1320. doi:10.1038/npp.2014.318.
42. Perkins K, Lerman C. Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics. Clin Pharmacol Ther. 2011;89(3):460-463. doi:10.1038/clpt.2010.254.
43. Zachary RS. Shipley Institute of Living Scale - Revised Manual. Los Angeles, CA: Western Psychological Services; 2000.
44. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33;quiz 34-57. www.ncbi.nlm.nih.gov/pubmed/9881538. Accessed August 29, 2014.
45. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127. www.ncbi.nlm.nih.gov/pubmed/1932883. Accessed August 29, 2014.
46. Perkins KA, Karelitz JL, Jao NC. Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob Res. 2013;15(5):978-982. doi:10.1093/ntr/nts205.
47. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289-294. www.ncbi.nlm.nih.gov/pubmed/3954551. Accessed August 29, 2014.
48. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3(1):7-16. doi:10.1080/14622200020032051.
49. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063-1070. www.ncbi.nlm.nih.gov/pubmed/3397865. Accessed August 29, 2014.
50. Brown R, Burgess E, Sales S, Whiteley J. Reliability and validity of a smoking timeline follow-back interview. Addict Behav. 1998(12):101-112.
51. Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction. 2013;108(11):1962-1968. doi:10.1111/add.12273.
52. Perkins KA, Lerman C. An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology (Berl). 2014;231(1):1-11. doi:10.1007/s00213-013-3364-6.
53. Broadway JM, Engle RW. Individual differences in working memory capacity and temporal discrimination. PLoS One. 2011;6(10):e25422. doi:10.1371/journal.pone.0025422.
54. Macmillan NACCD. Detection theory: a user's guide. New York, NY: Psychology Press; 2008.
55. Jech R, Dusek P, Wackermann J, Vymazal J. Cumulative blood oxygenation-level-dependent signal changes support the 'time accumulator' hypothesis. Neuroreport. 2005;16(13):1467-1471. www.ncbi.nlm.nih.gov/pubmed/16110273. Accessed August 29, 2014.
56. Dusek P, Jech R, Sieger T, et al. Abnormal activity in the precuneus during time perception in Parkinson's disease: an fMRI study. PLoS One. 2012;7(1):e29635. doi:10.1371/journal.pone.0029635.
57. Vohs KD, Schmeichel BJ. Self-regulation and the extended now: controlling the self alters the subjective experience of time. J Pers Soc Psychol. 2003;85(2):217-230. www.ncbi.nlm.nih.gov/pubmed/12916566. Accessed August 29, 2014.
58. Block RA, Zakay D. Prospective and retrospective duration judgments: a meta-analytic review. Psychon Bull Rev. 1997;4(2):184-197. doi:10.3758/bf03209393.
59. Senecal N, Wang T, Thompson E, Kable JW. Normative arguments from experts and peers reduce delay discounting. Judgm Decis Mak. 2012;7(5):568-589. www.ncbi.nlm.nih.gov/pubmed/23596504.
60. Mazur JE. An adjusting amount procedure for studying delayed reinforcement. In: Commons ML, Mazur, JE, Nevin, JA, Rachlin, H, eds. Quantitative Analysis of Behavior: The Effects of Delay and of Intervening Events on Reinforcement Value. Vol 5. Hillsdale, NJ: Lawrence Erlbaum Associates; 1987:55-73.
61. Halfmann K, Hedgcock W, Kable J, Denburg NL. Individual differences in the neural signature of subjective value among older adults. Soc Cogn Affect Neurosci. 2016;11(7):1111-1120. doi:10.1093/scan/nsv078.
62. Cox KM, Kable JW. BOLD subjective value signals exhibit robust range adaptation. J Neurosci. 2014;34(49):16533-16543. doi:10.1523/JNEUROSCI.3927-14.2014.
63. Richards JB, Zhang L, Mitchell SH, de Wit H. Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav. 1999;71(2):121-143. doi:10.1901/jeab.1999.71-121.
64. Reynolds B, Schiffbauer R. Measuring state changes in human delay discounting: an experiential discounting task. Behav Processes. 2004;67(3):343-356. doi:10.1016/j.beproc.2004.06.003.
65. Barkley RA, Murphy KR, Bush T. Time perception and reproduction in young adults with attention deficit hyperactivity disorder. Neuropsychology. 2001;15(3):351.
66. Smith A, Cubillo A, Barrett N, et al. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination. Biol Psychiatry. 2013;74(8):615-622. doi:10.1016/j.biopsych.2013.03.030.
67. Solanto MV, Marks DJ, Wasserstein J, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010;167(8):958-968. doi:10.1176/appi.ajp.2009.09081123.
68. Solanto MV, Marks DJ, Mitchell KJ, Wasserstein J, Kofman MD. Development of a new psychosocial treatment for adult ADHD. J Atten Disord. 2008;11(6):728-736. doi:10.1177/1087054707305100.
69. Kirby KN, Marakovic NN. Delay-discounting probabilistic rewards: rates decrease as amounts increase. Psychon Bull Rev. 1996;3(1):100-104. doi:10.3758/BF03210748.
70. Kirby KN. Bidding on the future: evidence against normative discounting of delayed rewards. J Exp Psychol Gen. 1997;126(1):54-70. doi:10.1037/0096-3445.126.1.54.
71. Kowal BP, Yi R, Erisman AC, Bickel WK. A comparison of two algorithms in computerized temporal discounting procedures. Behav Processes. 2007;75(2):231-236. doi:10.1016/j.beproc.2007.02.005.
72. Navarick DJ. Discounting of delayed reinforcers: measurement by questionnaires versus operant choice procedures. Psychol Rec. 2004;54(1):85-94. doi:://WOS:000188964800006.
73. Madden GJ, Begotka AM, Raiff BR, Kastern LL. Delay discounting of real and hypothetical rewards. Exp Clin Psychopharmacol. 2003;11(2):139-145. www.ncbi.nlm.nih.gov/pubmed/12755458.
74. Ashare RL, Valdez JN, Ruparel K, et al. Association of abstinence-induced alterations in working memory function and COMT genotype in smokers. Psychopharmacology (Berl). 2013;230(4):653-662. doi:10.1007/s00213-013-3197-3.
75. Falcone M, Wileyto EP, Ruparel K, et al. Age-related differences in working memory deficits during nicotine withdrawal. Addict Biol. 2014;19(5):907-917. doi:10.1111/adb.12051.
76. Kenford Sl, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA. 1994;271(8):589-594. doi:10.1001/jama.1994.03510320029025.
77. Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004;72(3):371-381. doi:10.1037/0022-006x.72.3.371.
78. Ledgerwood DM, Arfken CL, Petry NM, Alessi SM. Prize contingency management for smoking cessation: a randomized trial. Drug Alcohol Depend. 2014;140:208-212. doi:10.1016/j.drugalcdep.2014.03.032.
79. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev. 2015;5:CD004307. doi:10.1002/14651858. CD004307.pub5.
80. Halpern SD, French B, Small DS, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med. 2015;372(22):2108-2117. doi:10.1056/NEJMoa1414293.
81. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009;360(7):699-709. doi:10.1056/NEJMsa0806819.
82. Roll JM. Assessing the feasibility of using contingency management to modify cigarette smoking by adolescents. J Appl Behav Anal. 2005;38(4):463-467.
83. Krishnan-Sarin S, Duhig AM, McKee SA, et al. Contingency management for smoking cessation in adolescent smokers. Exp Clin Psychopharmacol. 2006;14(3):306-310. doi:10.1037/1064-1297.14.3.306.
84. Morean ME, Kong G, Camenga DR, et al. Contingency management improves smoking cessation treatment outcomes among highly impulsive adolescent smokers relative to cognitive behavioral therapy. Addict Behav. 2015;42:86-90. doi:10.1016/j.addbeh.2014.11.009.
85. Peters EN, Petry NM, Lapaglia DM, Reynolds B, Carroll KM. Delay discounting in adults receiving treatment for marijuana dependence. Exp Clin Psychopharmacol. 2013;21(1):46-54. doi:10.1037/a0030943.
86. Washio Y, Higgins ST, Heil SH, et al. Delay discounting is associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol. 2011;19(3):243-248. doi:10.1037/a0023617.
87. Blain B, Hollard G, Pessiglione M. Neural mechanisms underlying the impact of daylong cognitive work on economic decisions. Proc Natl Acad Sci USA. 2016;113(25):6967-6972. doi:10.1073/pnas.1520527113.